ABSTRACT Objectives: In the salivary glands of patients with primary Sjögren Syndrome (pSjS) an accumulation of dendritic cells (DCs) is seen, which is thought to play a role in stimulating local inflammation. Aberrancies in subsets of monocytes, generally considered the blood precursors for DCs, may play a role in this accumulation of DCs. This study is aimed at determining the level of mature CD14 low CD16+ monocytes in pSjS and their contribution to the accumulation of DCs in pSjS. Methods: Levels of mature and immature monocytes in patients with pSjS (n = 19) and controls (n = 15) were analysed by flow cytometry. The reverse transmigration system was used for generation of DCs generated from monocyte subsets. The phenotype of DCs in pSjS salivary glands was analysed using immunohistochemistry. In vivo tracking of monocyte subsets was performed in a mouse model. Results: Increased levels of mature CD14 low CD16+ monocytes were found in patients with pSjS (mean (SD) 14.5 (5.5)% vs 11.4 (3.4)%). These cells showed normal expression of chemokine receptor and adhesion molecules. Mature monocytes partly developed into DClysosome-associated membrane glycoprotein (LAMP)+ (19.6 (7.5)%) and CD83+ (16 (9)%) DCs, markers also expressed by DCs in pSjS salivary glands. Monocyte tracking in the non-obese diabetic (NOD) mouse showed that the homologue population of mature mouse monocytes migrated to the salivary glands, and preferentially developed into CD11c+ DCs in vivo. Conclusions: Mature monocytes are increased in pSjS and patient and mouse data support a model where this mature monocyte subset migrates to the salivary glands and develops into DCs.
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Primary Sjögren syndrome (pSjS) is an autoimmune disorder characterised by focal lymphocytic infiltrates in the salivary and lachrymal glands. 1 Although the pathogenesis remains to be fully elucidated, several findings indicate involvement of the innate immune system. These include increased expression of Toll-like receptors and upregulation of the type I interferon (IFN) system. [2] [3] [4] [5] Furthermore, in labial biopsies, increased numbers of dendritic cells (DCs) were observed. 6 Interestingly, in the non-obese diabetic (NOD) animal model for pSjS, a strong accumulation of DCs was observed prior to the appearance of infiltrates. 7 DCs are potent antigen-presenting cells and play a key role in the development of immune responses by stimulating T cells and boosting B cell responses. [8] [9] [10] Therefore, the increased presence of DCs is likely to play a role in the initiation and perpetuation of local immunity.
The increased presence of DCs in the pSjS salivary gland may involve aberrancies in the precursor population of blood monocytes. Interestingly, monocyte alterations have been described in other autoimmune conditions such as rheumatoid arthritis (RA) and diabetes, and include increased expression of Fc receptors, increased adhesion to extracellular matrix and shifts in monocyte subsets. [11] [12] [13] In humans, monocytes can be separated in two populations, based on expression of CD14 and CD16. The majority of monocytes are CD14+CD16-, but approximately 10% are CD14 low CD16+ and this is considered to be a relatively mature population. 14 15 CD16+ mature monocytes are further characterised by high levels of CX3CR1 and low levels of chemokine (C-C motif) receptor 2 (CCR2) and CD62L.
16 CD16-immature monocytes have been hypothesised to convert into mature CD16+, 17 which in turn develop into DCs. Indeed, CD16+ monocytes have been shown to preferentially develop into tissuetrafficking DCs in an in vitro model. 17 In the mouse system, the populations of Ly-6C high and Ly-6C low monocytes are considered to be homologous to the human CD16-and CD16+ subsets. 15 Supporting the idea of a kinetic relationship between the two subsets, in mice it has been shown that in vivo, Ly-6C high monocytes develop into Ly-6C low monocytes. 18 Previously, increased levels of mature monocytes were described in RA and infectious diseases such as HIV and sepsis. 13 19-21 In human pSjS, no data has been reported on the levels of mature monocytes. However, in the NOD mouse, 22 the mature monocyte subset is increased significantly. 23 The purpose of this study was to determine if the mature monocyte subset is expanded in pSjS and if DCs derived from this subset contribute to the accumulation of activated DCs observed in the salivary glands of these patients.
MATERIALS AND METHODS Patients and controls
Heparinised blood samples were obtained from 19 female patients with pSjS fulfilling the AmericanEuropean consensus criteria 24 Labial biopsies of six subjects were obtained during diagnostic biopsy procedures at the Erasmus MC. Two patients were diagnosed as pSjS according to the criteria mentioned above, and four did not meet any of the objective criteria for pSjS and were considered controls. Parotid biopsies of two patients fulfilling the criteria for pSjS were obtained at the University Medical Center Groningen, Groningen, The Netherlands in the course of another study. 25 All subjects gave informed consent and experimental procedures were approved by the Medical Ethical Committees of Erasmus MC and University Medical Center Groningen.
Mice
NOD/LTj mice were bred and housed in our own facility under specified pathogen-free conditions. All experimental procedures were approved by the Erasmus University Animal Ethical Committee.
Cell isolations
Peripheral blood mononuclear cells (PBMCs) were isolated from peripheral blood using a Ficoll gradient (Amersham, Little Chalfont, UK). When appropiate, CD16+ and CD16-populations were separated using CD16-microbeads and AutoMACS separation (Miltenyi, Bergisch Gladbach, Germany).
Flow cytometry
Human cell samples were stained using fluorescein isothiocyanate (FITC) anti-CX3CR1 (MBL International, Woburn, Massachusetts, USA), PE anti-CCR2, PE anti-DC-specific intercellular adhesion molecule-3-grabbing non-integrin (SIGN) (R&D Systems Inc., Minneapolis, Minnesota, USA), PE anti-human leukocyte antigen (HLA)-DR, PE anti-CD62L, PE anti-CD80, PE anti-CD86, PE anti-CD16 and APC anti-CD14 (BD Biosciences, San Jose, California, USA), PE anti-CD83 and PE-DC-lysosome-associated membrane glycoprotein (LAMP) (Immunotech, Marseille, France). Murine samples were stained using biotinylated anti-CD11c, followed by allophycocyanin (APC)-streptavidin (BD Biosciences).
Reverse transmigration assay
Development of DCs from monocytes was studied in a reverse transmigration assay. 17 Briefly, human umbilical vein endothelial cells (HUVECs) were grown to confluency on a collagen matrix (Allergan, Irvine, California, USA). PBMCs were depleted of naturak killer (NK) cells using CD56-microbeads (Miltenyi). CD16+ cells were then isolated using CD16-microbeads and labelled with 5(6)-carboxyfluorescein diacetate N-succinimidyl ester (Sigma Aldrich, Deisenhofen, Germany). CD16+ and CD16-cells were remixed and applied to the endothelial layer for 2 h. Afterwards, non-adherent cells were washed away and culture was continued for 48 h. Reverse transmigrated cells were then removed using 1 mM ethylenediaminetetraacetic acid (EDTA). All cultures used Ham F12 culture medium (BioWhittaker, Verviers, Belgium), supplemented with 20% fetal calf serum (FCS) (BioWhittaker), 50 mg/ml endothelial cell growth supplement (R&D Systems) and 100 mg/ ml heparin (Sigma).
Cytokine measurements
Levels of interleukin (IL)10, IL1b, tumour necrosis factor (TNF)a and IFNc were determined using a human cytokine 25-plex AB Bead kit (Biosource, Camarillo, California, USA). Measurements were performed on a Luminex XYP (Luminex, Austin, Texas, USA) and analysed using StarStation software V.2.0 (Applied Cytometry Systems, Sheffield, UK).
Immunohistochemistry
Labial and parotid biopsies were snap-frozen in Tissue-Tek (Sakura, Zoetermeer, The Netherlands). Cryostat sections (6 mm) were prepared and fixed with cold methanol and acetone. To limit background staining, an avidin/biotin block was used (Vector Laboratories, Burlingame, California, USA). Slides were incubated with anti-DC-LAMP (Immunotech, Marseille, France), anti-DC-SIGN or IgG control (BD Biosciences) followed by biotinylated rabbit anti-mouse IgG and subsequent streptavidin-ABComplex-AP (Dako A/S, Glostrup, Denmark). Alkaline phosphatase (AP) label was developed using new fuchsine staining (Chroma, Stuttgart, Germany). Slides were counterstained with haematoxylin (Merck, Whitehouse Station, New Jersey, USA).
In vivo monocyte tracking
Monocyte subsets were labelled as described previously. 26 Briefly, for labelling of Ly-6C low monocytes, mice were injected with Fluoresbrite plain YG 0.5 micron microspheres (Polysciences Inc. Warrington, Pennsylvania, USA) intravenously in the tail vein. Before labelling of Ly-6C high monocytes, mice were injected with Cl 2 MDP (dichloromethyl diphosphonate; clodronate) liposomes intravenously in the tail vein. Clodronate was a gift of Roche Diagnostics GmbH, Mannheim, Germany. It was encapsulated in liposomes as described previously. 27 This results in a transient depletion of blood monocytes, followed by repopulation of Ly-6C high monocytes. 18 At 20 h later, these mice also received Fluoresbrite microspheres intravenously, thus labelling the Ly-6C high population. At 4 days later, submandibular glands (SMG) were removed and cleared of all adipose tissue and lymph nodes. Tissue was then digested using Liberase (Roche, Woerden, The Netherlands) treatment and cells were washed twice in phosphate-buffered saline (PBS) containing 10% FCS. Cell suspensions were then analysed by flow cytometry.
Statistics
For comparison of unpaired data, the Mann-Whitney U test was used. For comparison of paired data, the Wilcoxon signed ranks test was used. Correlations were calculated using Spearman rank test. All analyses were carried out using SPSS software (SPSS, Chicago, Illinois, USA), results were considered statistically significant if p,0.05.
RESULTS

Increase in mature monocytes in pSjS
PBMC were stained for CD14 and CD16 and frequencies of mature and immature monocyte subsets were determined by flow cytometry. The frequency of CD16+ mature monocytes was significantly increased in pSjS compared to healthy controls ( fig 1A) , while the frequency of CD16-immature monocytes was not altered significantly (data not shown). Several cytokines have been reported to induce the upregulation of CD16 on monocytes in vitro, including IL10. 28 Although levels of IL10 were increased in the serum of patients with pSjS 
Normal phenotype of mature monocytes in pSjS
Besides expression of CD16, mature monocytes are characterised as CCR2 low CD62L low CX3CR1 high . Expression of these markers was determined, as an aberrant expression pattern would have implications for the migration of this subset. Mature monocytes expressed low levels of CCR2 and CD62L and high levels of CX3CR1 (fig 2A) . For comparison, immature monocytes expressed low levels of CX3CR1 and high levels of CCR2 and CD62L ( fig 2B) . No differences were observed between pSjS and controls, indicating that the monocyte subsets are phenotypically normal in pSjS with regard to these migration markers and would be expected to show a normal migration pattern.
Mature monocytes are capable of developing into DC-LAMP+ dendritic cells
The mature monocyte subset has been described to preferentially develop into tissue trafficking DCs, 17 but the exact phenotype of these DCs is unknown. To determine the phenotype of DCs derived from the mature monocyte subset, the reverse transmigration model was used. In this system, monocytes develop into DCs while traversing through endothelial cells as well as the extracellular matrix, thus abolishing the need for addition of exogenous cytokines. 17 To specifically study DCs originating from mature monocytes, this subset was isolated from PBMCs obtained from controls, labelled with carboxyfluorescein succinimidyl ester (CFSE) and remixed with the original PBMCs. This total population was then used in the reverse transmigration system. After 48 h, the reverse transmigration fraction contained a clear population of DCs with cell surface ruffling and dendrites ( fig 3A) . This population contained CFSE+ and CFSE-cells, indicating that these cells are of CD16+ mature and CD16-immature origin. DCs derived from both monocyte subsets uniformly expressed HLA-DR at high levels ( fig 3B) . Previously, our group has reported the increased presence of CD83+ and CD1a+ DC in the salivary glands of patients with pSjS. 6 CD83 was present on a considerable proportion of DCs generated, especially in those generated from mature monocytes ( fig 3B) . CD1a+ DC were only rarely generated (2%), and originated solely from immature monocytes (data not shown).
Recently, two more DC markers were described, DC-SIGN and DC-LAMP. 29 30 Expression of DC-SIGN was observed in up to 70% of DCs derived from mature monocytes, but was more common in DCs derived from the immature subset (up to 89%, fig 3B) . Contrary to this, expression of DC-LAMP was present in significantly larger proportions of DCs derived from mature monocytes ( fig 3B) . Similarly, expression of activation marker CD80 also tended to be higher in CD14 low CD16+ derived DCs ( fig 3B) .
DC-LAMP+ DCs are present in lymphocytic infiltrates in pSjS salivary gland
Data on the expression of DC-SIGN and DC-LAMP in the salivary glands of patients with pSjS has not been reported thus far. Therefore, expression of these markers was studied in labial or parotid biopsies obtained from four patients with pSjS. Expression of DC-SIGN could readily be observed in all four patients in the lymphocytic infiltrates and scattered throughout the parenchyma (fig 4A) . DC-LAMP+ cells were clearly present as well, with an expression pattern restricted to the lymphocytic infiltrates (fig 4A) .
Mouse homologue subset of mature monocytes migrates to salivary gland and preferentially develops into DCs
To monitor monocyte trafficking in vivo, the NOD mouse model was used. This strain spontaneously develops lymphocytic infiltrates in the salivary glands similar to those seen in patients with pSjS 7 and exhibits an expansion of Ly6C low mature monocytes. 23 Ly-6C low mature and Ly-6C high immature monocytes were labelled in vivo using latex beads labelled with the fluorescent marker Yellow-Green (YG). 26 SMG were removed 4 days later and analysed for presence of YG+ cells by flow cytometry. Although SMG total cell suspensions show some autofluorescence, a clear population of YG+ cells could be observed in all mice (fig 5A) , regardless of the monocyte subset labelled. The YG+ population in the SMG was then further analysed for expression of the dendritic cell marker CD11c. YG+ cells derived from mature monocytes cells were largely positive for CD11c (mean 59 (14)%), indicating their dendritic nature ( fig 5B) . In contrast, expression of CD11c on YG+ cells derived from immature monocytes was significantly lower (mean 36 (8)%, fig 5B,C) . This supports the idea that although both populations migrate to the SMG, mature monocytes preferentially develop into tissue DCs.
DISCUSSION
This study shows that in pSjS the frequency of CD16+ mature monocytes is increased compared to controls. Similar data has been described for patients with RA, 13 19 although in our results, the increase in CD16+ monocytes in RA was less pronounced than that in pSjS (data not shown). The mature subset expresses normal levels of chemokine receptors and adhesion molecules. DCs derived from mature monocytes partly express DC-LAMP and CD83, a phenotype similar to DCs in pSjS salivary gland.
Increased levels of CD16+ monocytes have been described in systemic infection and sepsis, where cytokines were suggested to be the causal factor.
21 31 32 Since in our patient cohort no correlation between CD16+ frequency and these cytokines could be found, a straightforward cytokine effect appears to be Figure 3 Mature monocyte derived dendritic cells (DCs) partly express CD83 and DC-lysosome-associated membrane glycoprotein (LAMP). CD16+ monocytes were isolated from control peripheral blood mononuclear cells (PBMCs) by magnetic isolation and labelled using carboxyfluorescein succinimidyl ester (CFSE). Cells were then remixed and applied to the reverse transmigration system. A. After 48 h, reverse transmigrated cells were harvested and showed ruffled membranes. B. DCs were harvested and CFSE+ and CFSE-DCs were analysed separately for marker expression by flow cytometry. HLA-DR, human leukocyte antigen-DR; SIGN, specific intercellular adhesion molecule-3-grabbing non-integrin.
unlikely. Additionally, levels of mature monocytes did not correlate with disease duration, thus contradicting the idea that the increased frequency of this subset is simply due to an ongoing systemic inflammation.
The fate of mature monocytes after leaving the circulation has been poorly elucidated. Most data on the developmental fate of monocyte subsets has been derived from mouse studies that focused on the homologue population of Ly-6C low mature monocytes. 33 A recent report has shown that Ly-6C low monocytes can develop into lung DCs but not spleen DCs, 34 thus indicating that this subset may be mainly involved in the seeding of DCs in non-lymphoid organs. In the NOD mouse, a spontaneous model for pSjS, 22 an increase in mature monocytes and salivary gland infiltrating CD11c+ DCs was observed. 7 23 This study shows that mature monocytes indeed have the capacity to migrate into the submandibular glands, and develop into CD11c+ cells more often then their immature counterparts. In mice, expression of CD11c is mainly found on DCs and alveolar macrophages, with only low levels being expressed by other macrophage subsets. 35 36 Given the high expression of CD11c on Ly-6C low monocyte derived cells in the NOD salivary gland, these cells are most likely DCs. Recently, the NOD mouse model was reported to lack longitudinal stability with regard to the development of SjS-like symptoms. 37 In the current study, the decrease in salivary flow was not analysed, so a direct link between monocyte infiltration and decreased salivary flow could not be established. However, the results do show that Ly-6C low monocytes are capable of migrating to the salivary glands and preferentially develop into DCs. Although the populations of CD16+ and Ly-6C low monocytes cannot be taken as completely identical, this strongly supports the idea that mature monocytes preferentially differentiate into tissue DCs.
The inhibitory FcGRIIb marker has been implicated in maturation of DCs from monocytes in humans. Blocking this receptor results in increased DC maturation and activation, suggesting the FcGRIIb is a marker of relatively immature monocytes. 38 Indeed, expression of this receptor is decreased in CD16+ monocytes compared to CD16-monocytes as determined at the mRNA level (data not shown), confirming the hypothesis that CD16+ monocytes are more prone to develop into DCs than their CD16-counterpart.
Previously our group has shown that increased numbers of CD83+ and CD1a+ DCs are present in labial salivary glands of patients with pSjS. 6 In addition to this, it is shown here that the recently described markers DC-SIGN and DC-LAMP 29 30 are expressed by DCs in pSjS labial and parotid salivary glands, with expression of DC-LAMP restricted to the lymphocytic infiltrates. The importance of DCs for the formation of pathological infiltrates is shown by the fact that insulitis does not develop in the absence of macrophages and DCs. Furthermore, specific expansion of the DC population in a mouse model results in the formation of lymphocytic infiltration of the salivary glands. 39 40 To test if mature monocytes can develop in vitro into DCs displaying the phenotype seen in salivary glands, the reverse transmigration system was used. 17 This system allows for monocytes to rapidly differentiate into DCs without the need for addition of cytokines. The cells used in this assay are obviously still capable of producing cytokines themselves, and these may impact the process in a paracrine fashion. Therefore, this system should not be considered as ''cytokine-free'', but rather as a closer resemblance of the physiological environment than cultures in the presence of excess amounts of exogenous cytokines. Both monocyte subsets developed into DCs expressing high levels of HLA-DR, with a large proportion of cells also expressing DC-SIGN. Expression of CD83 and DC-LAMP was detected in particular on DCs derived from mature monocytes. A similar trend was observed for CD80, indicative of a more activated DC phenotype. This is in line with previous observations, where increased expression of CD86 was observed in CD16+ derived DC. 41 Only low numbers of CD1a+ DCs were detected, and originated solely from immature monocytes. This indicates that the CD1a+ DCs present in the SjS salivary gland may be a separate subset from the DCs displaying the activated phenotype. These results originate from in vitro experiments, which lack the local influence of the salivary gland. Cytokines produced by the glandular epithelium or infiltrating immune cells may also impact the differentiation of DCs, leading to different expression patterns than those described here. Therefore, although this data shows that mature monocytes have the capacity to develop into activated DCs, whether they preferentially do so specifically in salivary glands requires further confirmation in vivo.
In summary, patients with pSjS show increased numbers of mature CD16+ monocytes, which have the capacity to develop into CD83+ and DC-LAMP+ DCs, similar to the type of DC observed in salivary gland infiltrates in patients with pSjS. Direct tracking of monocyte subsets is not possible in humans due to ethical restraints, but our studies in the NOD mouse support the model of the mature monocyte subset migrating to the salivary glands and preferentially developing into DCs.
